Search research articles
Contact Us
Filters
Showing results (341-350 of 359) with videos related to
Page
of 36
Sort By:
Hemasphere
|
June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
Kamel Laribi, Alix Baugier de Materre, David Ghez, et al.
British Journal of Haematology
|
August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
American Journal of Hematology
|
April 5, 2019
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group
Anne Quinquenel, Sophie Godet, Caroline Dartigeas, et al.
Science Translational Medicine
|
June 10, 2021
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains
Mathieu Mateo, Stéphanie Reynard, Alexandra Journeaux, et al.
Blood
|
November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Nature Communications
|
August 15, 2024
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
François Virard, Stéphane Giraud, Mélanie Bonnet, et al.
Blood Advances
|
November 29, 2021
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
Cristina Bagacean, Rémi Letestu, Chadi Al-Nawakil, et al.
BMJ Global Health
|
February 17, 2026
COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024
Julie Garon Carlton, Eva Bazant, Chelsey Griffin, et al.
Cancer
|
April 15, 2026
Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study
Arthur Coste, Nanthara Sritharan, Anne Lok, et al.
Blood
|
February 18, 2021
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 359) with videos related to
Sort By:
Page
of 36
Hemasphere
|
June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
Kamel Laribi, Alix Baugier de Materre, David Ghez, et al.
British Journal of Haematology
|
August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
American Journal of Hematology
|
April 5, 2019
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group
Anne Quinquenel, Sophie Godet, Caroline Dartigeas, et al.
Science Translational Medicine
|
June 10, 2021
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains
Mathieu Mateo, Stéphanie Reynard, Alexandra Journeaux, et al.
Blood
|
November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Nature Communications
|
August 15, 2024
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
François Virard, Stéphane Giraud, Mélanie Bonnet, et al.
Blood Advances
|
November 29, 2021
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
Cristina Bagacean, Rémi Letestu, Chadi Al-Nawakil, et al.
BMJ Global Health
|
February 17, 2026
COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024
Julie Garon Carlton, Eva Bazant, Chelsey Griffin, et al.
Cancer
|
April 15, 2026
Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study
Arthur Coste, Nanthara Sritharan, Anne Lok, et al.
Blood
|
February 18, 2021
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, et al.
Page
of 36